Development of circulating biomarkers for early and advanced breast cancer
Early work uncovered HCG1745306 isoform CRA-a, and histone H1.2 as potential
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Early work uncovered HCG1745306 isoform CRA-a, and histone H1.2 as potential
particularly in the monitoring and management of bone and soft tissue tumors. By analyzing circulating biomarkers such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), microRNAs (miRNAs), exosomes…
Indian population regarding the biomarker levels. Based on the western data, analysis of five circulating biomarkers (MMP-9, Il-6, CRP, Fibrinogen and D-Dimer) was done to investigate their ... Fibrinogen and D-Dimer…
analysis. Pathway analysis was subsequently performed on the biomarkers found to be associated with DR. We identified a significant difference in circulating levels of: soluble ICAM-1 (p < 0.0001), asymmetric ... with…
Intraductal papillary mucinous neoplasm (IPMN) is a precursor cystic lesion to pancreatic
high mortality rate. In light of this, there is a need to identify sensitive biomarkers that could be useful in early detection and in following the progression of the disease ... suggesting that they were being…
Nanotechnology for Circulating Tumor Biomarker Analysis Circulating biomarkers are essential for cancer diagnosis and progression monitoring. Nowadays, it is commonly accepted and widely highlighted the need to discover…
cells as biomarkers of the tumor angiogenic status. Peptide sequences specifi c for these circulating biomarkers represent a new approach in angiogenic medicine and can be used for several diff
diagnosis in accordance with established guidelines. Hemoglobin A1C, fructosamine, and anhydroglucitol are among the circulating biomarkers of glycaemia that are utilized in the medical management of diabetes and are…
ideal for development into diagnostic tests. Emerging evidences indicated that circulating miRNAs exert a role as noninvasive biomarkers for cancer diagnostic and prognostic indexes with prospective. In this mini review
Cardiovascular diseases (CVD) are one of the major causes of death worldwide
Statement of the Problem: Metabolic changes in Type-2 Diabetes-Mellitus (T2DM
cancer. In addition, compared with traditional surgical approaches and other biochemical tests, circulating DNA as a biomarker, owns many obvious advantages. It is easily accessible, reliable, reproducible and early…
instability, PD-L1expression, gene expression profiles, and tumor microenvironment characteristics. Emerging areas such as circulating biomarkers,neoantigens, and digital pathology are also explored. The review…
Circulating miRNAs have the potential as cancer biomarkers but no consolidated guidelines are established for discovery analyses. Several issues (e.g. data normalization, expected miRNA up-regulation in one of classes
detect and monitor myocardial injury. Some studies have considered a possible role of circulating miRNAs as biomarkers for atherosclerotic disease; in other researches miRNAs seem to play a determinant role ... cellular…
Circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA) and Extracellular Vesicles (ECVs) hold the key to understanding the biology of tumor metastasis and provide a biomarker to noninvasively measure ... several…
system nature of ageing. In Markage EU Project, they have been identified a set biomarkers of ageing which, as a combination of parameters with appropriate weighting, would measure biological ... comparison between GO…
Cerebral ischemia or ischemic stroke is mainly attributed to vascular and circulation disorders. Among protein biomarkers, RNA profiles have also been identified as markers of ischemic stroke. MicroRNA-145 expression…
For authors and organisers
Find the right journal for your paper and submit your manuscript.